Using NIR Spectroscopy to Quantify Binary Ranitidine Hydrochloride Polymorphic Mixtures

McGoverin C.M. Ho L.C.H. Zeitler J.A. Strachan C.J. Gordon K.C. Rades T. , “Quantification of binary polymorphic mixtures of ranitidine hydrochloride using NIR spectroscopy”, Vibr. Spectrosc. 41(2), 225–231 (2006).

Brittain H.G. , “Spectral Methods for the Characterization of Polymorphs and Solvates”, J. Pharmaceut. Sci. 86(4), 405–412 (1997).

Brittain H.G. , Physical Characterization of Pharmaceutical Solids. Marcel Dekker, New York (1995).

Mirmehrabi M. Rohani S. Murthy K.S.K. Radatus B. , “Characterization of tautomeric forms of ranitidine hydrochloride: Thermal analysis, solid-state NMR, X-ray”, J. Crystal Growth 260(3–4), 517–526 (2004).

Mirmehrabi M. Rohani S. Murthy K.S.K. Radatus B. , “Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms”, Int. J. Pharmaceutics 282(1–2), 73–85 (2004).

Bernstein J. , Polymorphism in Molecular Crystals. oxford university Press, oxford (2002).

Sertsou G. Agatonovic-Kustrin S. Rades T. , “The use of DRIFTS to analyze binary mixtures of two polymorphic forms of ranitidine-HCl using only one specific peak”, Internet J. Vibr. Spectrosc. (online computer file) 3(5), (1999).

Agatonovic-Kustrin S. Rades T. Wu V. Saville D. Tucker I.G. , “Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPd”, J. Pharmaceut. Biomed. Anal. 25(5–6), 741–750 (2001).

Pratiwi D. Fawcett J.P. Gordon K.C. Rades T. , “Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis”, Eur. J. Pharmaceut. Biopharmaceut. 54(3), 337–341 (2002).

The European Agency for the Evaluation of Medicinal Products, FNfG, EMEA/CVMP/961/01, CPMP/QWP/3309/01.